Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells

Gastroenterology

Volumn 142, Issue 3, 2012, Pages 521-530.e3

  Zhang, Yu ^a   Du, Xiaoli ^a   Wang, Chengji ^b   Lin, Dechen ^a   Ruan, Xia ^a   Feng, Yanbin ^a   Huo, Yanqiu ^a   Peng, Haiyong ^a   Cui, Jinglu ^a   Zhang, Tongtong ^a   Wang, Yongquan ^a   Zhang, Hongbing ^a   Zhan, Qimin ^a   Wang, Mingrong ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b Linzhou People's Hospital   (China)

Author keywords

Cell Death; Neoplasm; Signaling; Transcriptional Regulation

Indexed keywords

BETA CATENIN; DNA NUCLEOTIDYLEXOTRANSFERASE; POLO LIKE KINASE 1; STAT3 PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; COLONY FORMATION; ESOPHAGUS CANCER; FLUORESCENCE ACTIVATED CELL SORTING; GEL MOBILITY SHIFT ASSAY; IMMUNOBLOTTING; IMMUNOCHEMISTRY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR XENOGRAFT;

EID: 84857636386     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.11.023     Document Type: Article

References (35)

1. J.N. Ihle STATs: signal transducers and activators of transcription Cell 84 1996 331 334
2. J.E. Darnell Jr STATs and gene regulation Science 277 1997 1630 1635
3. J. Bromberg Stat proteins and oncogenesis J Clin Invest 109 2002 1139 1142
4. D.E. Levy, C.K. Lee What does Stat3 do? J Clin Invest 109 2002 1143 1148
5. H. Yu, R. Jove The STATs of cancernew molecular targets come of age Nat Rev Cancer 4 2004 97 105
6. S. Huang Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications Clin Cancer Res 13 2007 1362 1366
7. H. Yu, M. Kortylewski, D. Pardoll Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment Nat Rev Immunol 7 2007 41 51
8. P. Yue, J. Turkson Targeting STAT3 in cancer: how successful are we? Expert Opin Investig Drugs 18 2009 45 56
9. S. Yan, C. Zhou, W. Zhang Beta-catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma Cancer Lett 271 2008 85 97
10. M. Petronczki, P. Lenart, J.M. Peters Polo on the rise-from mitotic entry to cytokinesis with Plk1 Dev Cell 14 2008 646 659
11. T. Takaki, K. Trenz, V. Costanzo Polo-like kinase 1 reaches beyond mitosiscytokinesis, DNA damage response, and development Curr Opin Cell Biol 20 2008 650 660
12. V. Archambault, D.M. Glover Polo-like kinases: conservation and divergence in their functions and regulation Nat Rev Mol Cell Biol 10 2009 265 275
13. L.Y. Lu, X. Yu The balance of Polo-like kinase 1 in tumorigenesis Cell Div 4 2009 4
14. F. Eckerdt, J. Yuan, K. Strebhardt Polo-like kinases and oncogenesis Oncogene 24 2005 267 276
15. K. Strebhardt, A. Ullrich Targeting polo-like kinase 1 for cancer therapy Nat Rev Cancer 6 2006 321 330
16. P. Schoffski Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology Oncologist 14 2009 559 570
17. Y.B. Feng, D.C. Lin, Z.Z. Shi Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma Int J Cancer 124 2009 578 588
18. Y. Zhang, Y.B. Feng, X.M. Shen Exogenous expression of esophagin/SPRR3 attenuates the tumorigenicity of esophageal squamous cell carcinoma cells via promoting apoptosis Int J Cancer 122 2008 260 266
19. L. Gao, L. Zhang, J. Hu Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo Clin Cancer Res 11 2005 6333 6341
20. X. Liu, M. Lei, R.L. Erikson Normal cells, but not cancer cells, survive severe Plk1 depletion Mol Cell Biol 26 2006 2093 2108
21. P.K. Epling-Burnette, J.H. Liu, R. Catlett-Falcone Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression J Clin Invest 107 2001 351 362
22. M.A. Blaskovich, J. Sun, A. Cantor Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice Cancer Res 63 2003 1270 1279
23. T. Uchiumi, D.L. Longo, D.K. Ferris Cell cycle regulation of the human polo-like kinase (PLK) promoter J Biol Chem 272 1997 9166 9174
24. J.F. Bromberg, M.H. Wrzeszczynska, G. Devgan Stat3 as an oncogene Cell 98 1999 295 303
25. D.S. Aaronson, C.M. Horvath A road map for those who don't know JAK-STAT Science 296 2002 1653 1655
26. K. Strebhardt Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy Nat Rev Drug Discov 9 2010 643 660
27. D. Lin, Y. Zhang, Q. Pan PLK1 is transcriptionally activated by NF-{kappa}B during cell detachment and enhances anoikis resistance through inhibiting {beta}-catenin degradation in esophageal cancer Clin Cancer Res 17 2011 4285 4295
28. L. Chin, J.N. Andersen, P.A. Futreal Cancer genomics: from discovery science to personalized medicine Nat Med 17 2011 297 303
29. E.S. Lander Initial impact of the sequencing of the human genome Nature 470 2011 187 197
30. M. Steegmaier, M. Hoffmann, A. Baum BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo Curr Biol 17 2007 316 322
31. E. Caldenhoven, T.B. van Dijk, R. Solari STAT3beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription J Biol Chem 271 1996 13221 13227
32. P.K. Epling-Burnette, J.H. Liu, R. Catlett-Falcone Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression J Clin Invest 107 2001 351 362
33. J.F. Bromberg, M.H. Wrzeszczynska, G. Devgan Stat3 as an oncogene Cell 98 1999 295 303
34. S. Yan, C. Zhou, W. Zhang Beta-catenin/TCF pathway upregulates STAT3 expression in human esophageal squamous cell carcinoma Cancer Lett 271 2008 85 97
35. T. Uchiumi, D.L. Longo, D.K. Ferris Cell cycle regulation of the human polo-like kinase (PLK) promoter J Biol Chem 272 1997 9166 9174